Pharmaceuticals - Community Register

  

List of nationally authorised medicinal products for human use

Calcitonin

Product name: Calcitonin
Also marketed in the EU under the name(s): Alciton, Azucalcit, Azucalcitoni, Biocalcin, Bionocalcin, Bionocálcio, Cadens Gé, Calciben, Calcibio, Calcimon, Calciosint, Calcioton, Calciplus, Calcitene, Calcitex, Calcitonin, Calcitonina, Calcitonine, Calcivera, Calco, Calogen, Calsyn, Calsynar, Carbicalcin, Casalm, Catonin, Cibacalcin, Cibacalcina, Crocalcin, Diatin, Elcatonina CEPA, ELCIMEN, Ellecalcin, Eptacalcin, Genecalcin, Human-Calcitonin Novartis, Ipocalcin Fiale, Iricalcin, Kalsimin, Karil, Lachscalcito - Ratiopharm, Latonina, Miacalcic, Miadenil, Miakaril, Neostesin, Norcalcin, Nylex, Oseototal, Ospor Spray nasal, Osseocalcina, Osteobion, Osteocalcin, Osteoposan, Osteos, Osteotonina, Osteotonina Spray, Osteovis, Osticalcin, Ostifix, Ostinate, Ostosalm, Ostostabil, Ostulex, Prontocalcin, Rafacalcin, Rulicalcin, Salcat, Salmocalcin, Salmofar, Salmoten, Sical, Staporos, Steocalcin, Steocin, Tendolon, Tonocalcin, Tonocaltin, Tosicalcin, Turbocalcin, Ucecal
Active substance: Calcitonin (salmon)
Indication: Prevention of acute bone loss due to sudden immobilisation such as in patients with recent osteoporotic fractures
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/06/2003 Referral EMEA/H/A-12/462 (2003)1907 of 12/06/2003